[ Price : $8.95]
The Institute for Clinical and Economic Review asks FDA to reconsider the implications of its stated goal in a draft guidance on c...[ Price : $8.95]
FDA approves an additional indication for Mercks Keytruda with chemotherapy to treat unresectable advanced or metastatic malignant...[ Price : $8.95]
Congresswoman Nanette Barragn (D-CA) reintroduces the Prompt Approval of Safe Generic Drugs Act, legislation that would remove hur...[ Price : $8.95]
FDA tells Applied Therapeutics its govorestat is on track for the 11/28 PDUFA action date and will not need to go before an adviso...[ Price : $8.95]
Smiths Medical recalls (Class 1) several lots of its Bivona Neonatal/Pediatric and Adult Tracheostomy tubes due to a manufacturing...[ Price : $8.95]
FDA approves AstraZenecas Fasenra (benralizumab) for treating adult patients with eosinophilic granulomatosis with polyangiitis.[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Integrating Randomized Controlled Trials for Drug and Biolo...[ Price : $8.95]
Merck and Daiichi Sankyo say their HERTHENA-Lung02 Phase 3 trial evaluating patritumab deruxtecan in certain patients with locally...